Publications

01 Sep 2023
News

The Exchange: Where Ethics Meet Economics

Max Bazerman and Mike Luca (Image by John Ritter) What makes people behave the way they do—and to what degree are design choices influencing that? Associate Professor Mike Luca studies the design of online platforms, while Professor Max Bazerman’s work focuses on... View Details

Keywords: Jen McFarland Flint; Data Processing, Hosting, and Related Services; Information

Web

Team - Institute For Strategy And Competitiveness

by Professor Michael E. Porter and is based in the Institute for Strategy and Competitiveness at Harvard Business School. Faculty and staff engaged in research and education in value based health care form the core team at HBS. In... View Details

11 Dec 2012
First Look

First Look: Dec. 11

Back, Moving Forward: A Review of Group and Team-Based Research, edited by Margaret A. Neale and Elizabeth A. Mannix, 359-381. Emerald Group Publishing, 2012 Abstract Purpose-We review how team members' identities and interests affect... View Details

Keywords: Sean Silverthorne

21 Feb 2019
Blog Post

Machine Learning and Behavioral Economics

This is a repost from the recruiting blog. For John Bracaglia, his academic and professional careers have been driven by two themes: “machine learning and behavioral economics,” he says. “The two work... View Details

15 Apr 2014
First Look

First Look: April 15

Publications August 2013 American Economic Review Private Equity, Jobs, and Productivity By: Davis, Steven J., John Haltiwanger, Kyle Handley, Ron Jarmin, Josh Lerner, and Javier Miranda Abstract—Private equity critics claim that... View Details

Keywords: Sean Silverthorne

January 2020
Case

Sunset Limited or Full Speed Ahead? Amtrak Talks to Congress

By: John D. Macomber

Richard Anderson took the helm of Amtrak in 2017 after leading a successful turnaround at Delta Airlines. Amtrak is a US state owned enterprise with about $3.5 bn in annual revenue (and a large operating loss) that is responsible for substantial segments of passenger... View Details

Keywords: Railroad; Passenger Transportation; Urbanization; Cities; U.S. Congress; Infrastructure; Transition; Transportation; Rail Transportation; Climate Change; Urban Scope; Strategic Planning; Business and Government Relations; Rail Industry; United States

12 Jun 2018
First Look

New Research and Ideas, June 12, 2018

https://www.hbs.edu/faculty/Pages/item.aspx?num=52111 Learning to Become a Taste Expert By: Latour, Kathryn A., and John A. Deighton Abstract—Evidence suggests that consumers seek to become more expert about... View Details

Keywords: Dina Gerdeman

11 Sep 2008
News

9/11 victims recalled as names, not numbers

December 2013
Article

Measuring the Value of Process Improvement Initiatives in a Preoperative Assessment Center using Time-driven Activity-based Costing

By: Katy E. French, Heidi W. Albright, John C. Frenzel, James R. Incalcaterra, Augustin C. Rubio, Jessica F. Jones and Thomas W. Feeley

Background: The value and impact of process improvement initiatives are difficult to quantify. We describe the use of time-driven activity-based costing(TDABC)in a clinical setting to quantify the value of process improvements in terms of cost, time and personnel... View Details

Keywords: Quality Improvement; Value Agenda; Time-Driven Activity-Based Costing; Accounting; Health; Measurement and Metrics; Value; Health Industry; North and Central America

Find at Harvard

Web

Harvard Business School

appointed by President Obama to the board of trustees of the John F. Kennedy Center for the Performing Arts and to the President's Committee on the Arts and the Humanities. Deborah Wright MBA 1984 Deborah... View Details

March 2014 (Revised December 2014)
Case

Vision 2020: Takeda and the Vaccine Business

By: John A. Quelch and Margaret L. Rodriguez

In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details

Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Pharmaceutical Industry

October 2008
Class Lecture

Marketing as Competitive Advantage: Fundamentals

By: Das Narayandas, David E. Bell, Anita Elberse, John T. Gourville, David B. Godes, John A. Quelch, Gail J. McGovern, Luc R. Wathieu and Marta Wosinska

Marketing as Competitive Advantage: Fundamentals will help today's business executives and tomorrow's business leaders understand the key elements of a successful marketing strategy. The multimedia resource includes video lectures by Harvard Business School faculty,... View Details

Keywords: Customers; Framework; Marketing Strategy; Product Positioning; Planning; Competitive Advantage; Segmentation

29 May 2012
First Look

First Look: May 29

What Do Managers Do? Exploring Persistent Performance Differences among Seemingly Similar Enterprises Authors:Rebecca Henderson and Robert Gibbons Publication:In The Handbook of Organizational Economics, edited by Robert Gibbons and View Details

Keywords: Sean Silverthorne

October 2013 (Revised June 2014)
Case

Demarketing Soda in New York City

By: John A. Quelch, Margaret L. Rodriguez, Carin-Isabel Knoop and Christine Snively

In 2013, New York City Mayor Michael Bloomberg tried and failed to institute a ban on serving sizes of large sugary beverages. Obesity posed a large public health risk to the city. Mayor Bloomberg's proposed ban was one of many attempts to combat the rising threat of... View Details

Keywords: Soda; Public Health; Business And Public Policy; Obesity; Business and Government Relations; Public Sector; Strategy; Marketing Strategy; Marketing; Health; City; Food and Beverage Industry; New York (city, NY)

February 2002
Case

Fighting AIDS and Pricing Drugs

By: John T. Gourville

In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant... View Details

Keywords: Developing Countries and Economies; Patents; Price; Strategy; Globalized Markets and Industries; Pharmaceutical Industry